Fortical (calcitonin salmon recombinant) / Enteris  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fortical (calcitonin salmon recombinant) / Enteris
NCT00620854: A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women

Completed
2
24
US
Recombinant Salmon Calcitonin (rsCT), Fortical® nasal spray, Oral Tablet, Nasal Spray
Tarsa Therapeutics, Inc.
Osteoporosis
04/08
04/08
NCT00803686: A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women

Completed
2
12
US
Oral rsCT tablet, rsCT, Oral Placebo Tablet, Placebo, Fortical (rsCT) nasal spray, Fortical nasal spray
Tarsa Therapeutics, Inc.
Phase 1 Pharmacodynamic Study
01/09
01/09

Download Options